299.20DKK+0.91%Mkt Cap: 1.33T DKKP/E: 10.92Last update: 2026-05-13
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare D…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)10.92
P/E (Forward)14.00
PEG3.44
P/B6.55
P/S4.05
EV/EBITDA8.36
EV/Revenue4.44
EPS (TTM)27.41
EPS (Forward)21.37
Cash Flow & Leverage
FCF Yield-0.91%
FCF Margin-3.67%
Operating CF119.10B DKK
CapEx (TTM)90.11B DKK
Net Debt/EBITDA0.72
Net Debt124.76B DKK
Technical
SMA 50256.05 (+16.9%)
SMA 200314.74 (-4.9%)
Beta0.35
S&P 52W Chg24.23%
Avg Vol (30d)6.01M
Avg Vol (10d)7.27M
Technical Indicators
RSI (14)69.0
MACD12.5465
MACD Signal9.3293
MACD Hist.+3.2171
BB Upper310.26 DKK
BB Middle272.80 DKK
BB Lower235.34 DKK
BB Width27.46%
ATR (14)10.38 DKK
Vol Ratio (20d)0.85x
52W Range
224.2524% of range533.40
52W High533.40 DKK
52W Low224.25 DKK
Profitability
Gross Margin80.98%
EBITDA Margin53.04%
Profit Margin33.14%
Oper. Margin61.57%
ROE52.79%
ROA18.87%
Revenue Growth24.00%
Earnings Growth67.10%
Balance Sheet
Debt/Equity0.67
Current Ratio0.79
Quick Ratio0.54
Book Value/Sh45.71 DKK
Cash/Share4.868 DKK
Dividends
Fwd Div Rate15.90 DKK
Trail. Div Rate11.70 DKK
Div. Yield5.31%
5Y Avg Yield1.78%
Payout Ratio42.69%
Ex-Div DateMar 27, 2026
Pay Date—
Splits
Last Split2:1
Split DateSep 13, 2023
Ownership
Shares Out.3.36B
Float3.19B
Insiders5.28%
Institutions32.70%
Analyst Consensus
Rating2.7 (Hold)
Target (Mean)307.99 DKK
Target Range175.00 DKK – 444.00 DKK
# Analysts23
Company
Market Cap1.33T DKK
Enterprise Value1.45T DKK
Revenue (TTM)327.80B DKK
Gross Profit250.28B DKK
Net Income (TTM)102.43B DKK
Revenue/Share73.77 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees67.9K
Last Price299.20 DKK
CountryDK
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS6701002056